Psychedelics New Zealand begins prescribing MDMA for severe PTSD treatment It is the second nation to do so after its larger neighbour Australia Rowan DunneSeptember 4, 2026
AI and Autonomy AI flags heart disease from routine ECG test within seconds Artificial intelligence is making it easier to determine who needs a heart ultrasound most Rowan DunneSeptember 1, 2026
Medical and Pharmaceutical Revolution’s newly approved drug doubles pancreatic cancer survival time A 30-day course of Rasonque costs US$39,800 Rowan DunneAugust 31, 2026
Medical and Pharmaceutical Propanc Biopharma skyrockets from pancreatic cancer drug breakthrough Stock ascended by more than 150% Rowan DunneAugust 28, 2026
Medical and Pharmaceutical Artificial heart maker Picard soars from 39% revenue spike, narrowed net loss SynCardia's Total Artificial Heart serves as a temporary solution while patients wait for donors Rowan DunneAugust 24, 2026
Medical and Pharmaceutical AI-powered light scan could speed up targeted lung cancer treatments This technique, fluorescence lifetime imaging microscopy, could save patients and hospitals alot of money Rowan DunneJuly 13, 2026
Medical and Pharmaceutical Moroccan medtech leader T2S gets green light for Casablanca IPO T2S supplies, distributes, installs and maintains advanced medical equipment Rowan DunneJuly 7, 2026
Medical and Pharmaceutical BioMark expands lung cancer screening portfolio with patented urine test It is one of a select few pursuing this variety of diagnostics Rowan DunneJune 10, 2026
Medical and Pharmaceutical AI-powered blood test promises lung cancer detection 5 years in advance British scientists used the biopsy to detect a 14-protein blood signature linked to the disease Rowan DunneJune 4, 2026
Medical and Pharmaceutical International research surge highlights asbestos health crisis It's being overlooked in lung cancer screening, causing a record number of legal claims and may be deadlier than once thought Rowan DunneJune 2, 2026